PUBLICATIONS.

Selected publications by BASE facility scientists.

 

 

2021

Chappell KJ, Mordant FL, Li Z, Wijesundara DK, et al. 2021. First Report of a Phase 1 Randomised Trial of Molecular Clamp-Stabilised Spike Protein-Based and MF59-Adjuvanted Vaccine for SARS-CoV-2. The Lancet.

Watterson D, Wijesundara DK, Modhiran N, et al. 2021. Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Clinical & Translational Immunology. 10(4)

Mercer TR, Salit M. 2021 Testing at scale during the COVID-19 pandemic. Nature Review Genetics. May 4.

Deveson IW, Gong B, Lai K, LoCoco JS, et. al., 2021 Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nature Biotechnology. Apr 12.

Yap K, Du J, Rehm FBH, Tang SR, Zhou Y, et. al., 2021 Yeast-based bioproduction of disulfide-rich peptides and their cyclization via asparaginyl endopeptidases. Nature Protocols. Mar;16(3):1740-1760.

Madala BS, Reis ALM, Deveson IW, et. al., 2021 Chimeric synthetic reference standards enable cross-validation of positive and negative controls in SARS-CoV-2 molecular tests. Scientific Reports. Jan 29;11(1):2636.

2020

Henry MN, MacDonald MA, Orellana CA, Gray PP, Gillard M, Baker K, Nielsen LK, Marcellin E, Mahler S, Martinez VS. 2020. Attenuating apoptosis in Chinese hamster ovary cells for improved biopharmaceutical production. Biotechnology and Bioengineering. 117(4)

Playford EG, Munro T, Mahler SM, et al. 2020. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. The Lancet Infectious Diseases. 4(20)

Sun B, Gillard M, Wu Y, Wu P, Xu ZP, Gu W. 2020. Bisphosphonate Stabilized Calcium Phosphate Nanoparticles for Effective Delivery of Plasmid DNA to Macrophages. ACS Applied Bio Material. 3(2)

Nadar S, Shooter G, Somasundaram B, Shave E, Baker K, Lua LHL. 2020. Intensified Downstream Processing of Monoclonal Antibodies Using Membrane Technology. Biotechnology Journal. Mar;16(3):e2000309.